Tequin Labeling Notes In Vitro Activity Vs. Penicillin-Resistant S. Pneumoniae
Executive Summary
Labeling for Bristol-Myers Squibb's Tequin discusses the in vitro efficacy of the quinolone antibiotic against penicillin-resistant Streptococcus pneumoniae.
You may also be interested in...
Bristol Tequin Labeling Update Includes New Indication, Glucose Warning
A supplemental approval for Bristol-Myers Squibb's Tequin adds an indication for uncomplicated skin and skin structure infections - but also adds language on QT prolongation and blood glucose disturbances
Bristol Tequin Labeling Update Includes New Indication, Glucose Warning
A supplemental approval for Bristol-Myers Squibb's Tequin adds an indication for uncomplicated skin and skin structure infections - but also adds language on QT prolongation and blood glucose disturbances
Bayer Avelox Uncomplicated Skin Infection Use Clears FDA
Bayer is studying Avelox for complicated skin infections, the company said following the approval of the fluoroquinolone for uncomplicated skin infection.